Upregulation of fibronectin following loss of p53 function is a poor prognostic factor in ovarian carcinoma with a unique immunophenotype

Cell Commun Signal. 2020 Jul 7;18(1):103. doi: 10.1186/s12964-020-00580-3.

Abstract

Background: We previously demonstrated that ovarian high grade serous carcinomas (OHGSeCa) and ovarian clear cell carcinomas (OCCCa) with an HNF-1β+/p53+/ARID1A+ immunophenotype were associated with the worst unfavorable prognosis. To clarify the molecular mechanisms underlying this finding, we focused on alterations in the p53 signaling pathway in these tumors.

Methods: Changes in cell phenotype and function following knockdown of wild-type p53 (p53-KD) were assessed using OCCCa cells expressing endogenous HNF-1β and ARID1A. The prognostic significance of molecules that were deregulated following p53-KD was also examined using 129 OCCCa/OHGSeCa cases.

Results: p53-KD cells had increased expression of Snail, phospho-Akt (pAkt), and pGSK3β, and decreased E-cadherin expression, leading to epithelial-mesenchymal transition (EMT)/cancer stem cell (CSC) features. The cells also exhibited acceleration of cell motility and inhibition of cell proliferation and apoptosis. Next generation sequencing revealed that fibronectin (FN) expression was significantly increased in the p53 KD-cells, in line with our observation that wild-type p53 (but not mutant p53) repressed FN1 promoter activity. In addition, treatment of OCCCa cells with FN significantly increased cell migration capacity and decreased cell proliferation rate, independent of induction of EMT features. In clinical samples, FN/p53 scores were significantly higher in OCCCa/OHGSeCa with the HNF-1β+/p53+/ARID1A+ immunophenotype when compared to others. Moreover, high FN/high p53 expression was associated with the worst overall survival and progression-free survival in OCCCa/OHGSeCa patients.

Conclusion: These findings suggest that upregulation of FN following loss of p53 function may impact the biological behavior of OCCCa/OHGSeCa, particularly in tumors with an HNF-1β+/p53+/ARID1A+ immunophenotype, through alterations in cell mobility and cell proliferation. The accompanying induction of EMT/CSC properties and inhibition of apoptosis due to p53 abnormalities also contribute to the establishment and maintenance of tumor phenotypic characteristics. Video Abstract.

Keywords: ARID1A; Apoptosis; Cell mobility; Cell proliferation; Fibronectin; HNF-1β; Immunophenotype; Ovarian carcinoma; Prognosis; p53.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Cell Movement
  • DNA-Binding Proteins / metabolism
  • Epithelial-Mesenchymal Transition / genetics
  • Female
  • Fibronectins / genetics*
  • Fibronectins / metabolism
  • Gene Expression Regulation, Neoplastic
  • Hepatocyte Nuclear Factor 1-beta / metabolism
  • Humans
  • Immunophenotyping*
  • Kinetics
  • Middle Aged
  • Models, Biological
  • Multivariate Analysis
  • Neoplastic Stem Cells / metabolism
  • Neoplastic Stem Cells / pathology
  • Ovarian Neoplasms / metabolism*
  • Ovarian Neoplasms / pathology
  • Phenotype
  • Prognosis
  • Progression-Free Survival
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Transcription Factors / metabolism
  • Tumor Suppressor Protein p53 / metabolism*
  • Up-Regulation / genetics*

Substances

  • ARID1A protein, human
  • DNA-Binding Proteins
  • Fibronectins
  • HNF1B protein, human
  • RNA, Messenger
  • Transcription Factors
  • Tumor Suppressor Protein p53
  • Hepatocyte Nuclear Factor 1-beta